RAMPs change calcitonin receptor pharmacology from calcitonin-preferring to amylin-preferring by affecting receptor specificity and affinity
Treatment focuses on addressing the underlying cause, controlling symptoms, and preventing complications particularly foot injuries in patients with diabetes who cannot feel pain normally
Your body is highly skilled at filtering out waste particles
(Erstad 2022) Unfortunately, free phenytoin level is generally a send-out test with a slow turnaround time
Managing side effects during dose escalation Side effects with retatrutide are primarily gastrointestinal, and they follow a predictable pattern
Patients treated with a 2 mg dose of EGRIFTA (1 mg/formulation) for 52 weeks (T-T group) showed no change between Weeks 26 and 52 in mean trunk fat (increase of 0.1 kg in Study 1 and decrease of 0.5 kg in Study 2, respectively, compared with an increase of 1.4 kg in patients in the T-P group in Study 1 and an increase of 1.09 kg in Study 2, respectively) nor was there a change from Week 26 baseline in mean lean body mass (decrease of 0.1 kg in Study 1 and increase of 0.1 kg in Study 2, respectively, compared with a decrease of 1.8 kg in patients in the T-P group in Study 1 and a decrease of 1.7 kg in Study 2, respectively)
